- Home
- CVKD vs LDWY Comparison
CVKD vs LDWY Comparison
Compare CVKD & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$8.18
N/A
Current Price
$3.58
Company Overview
Basic Information| Metric | CVKD | LDWY |
|---|---|---|
| Founded | 2022 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7M | 6.2M |
| IPO Year | 2023 | 1991 |
Fundamental Metrics
Financial Performance| Metric | CVKD | LDWY |
|---|---|---|
| Price | $8.18 | $3.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $32.00 | N/A |
| AVG Volume (30 Days) | ★ 82.9K | 55.0K |
| Earning Date | 11-10-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.70 |
| Revenue | N/A | ★ $69,769,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $5.04 |
| Revenue Growth | N/A | ★ 121.91 |
| 52 Week Low | $6.42 | $3.11 |
| 52 Week High | $22.90 | $6.19 |
Technical Indicators
Market Signals| Indicator | CVKD | LDWY |
|---|---|---|
| Relative Strength Index (RSI) | 46.95 | 49.43 |
| Support Level | $6.55 | $3.43 |
| Resistance Level | $7.58 | $3.52 |
| Average True Range (ATR) | 0.65 | 0.12 |
| MACD | 0.14 | 0.04 |
| Stochastic Oscillator | 91.78 | 88.57 |
Price Performance
Historical Comparison CVKD
LDWY
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in industries: Specialty Ag, consisting of the Bloomia business.